CATX
Price
$3.46
Change
-$0.08 (-2.26%)
Updated
Sep 5 closing price
Capitalization
256.95M
73 days until earnings call
PROF
Price
$4.12
Change
-$0.30 (-6.79%)
Updated
Sep 5 closing price
Capitalization
125.27M
54 days until earnings call
Interact to see
Advertisement

CATX vs PROF

Header iconCATX vs PROF Comparison
Open Charts CATX vs PROFBanner chart's image
Perspective Therapeutics
Price$3.46
Change-$0.08 (-2.26%)
Volume$2.01M
Capitalization256.95M
Profound Medical
Price$4.12
Change-$0.30 (-6.79%)
Volume$33.19K
Capitalization125.27M
CATX vs PROF Comparison Chart in %
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. PROF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and PROF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CATX: $3.46 vs. PROF: $4.12)
Brand notoriety: CATX and PROF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CATX: 251% vs. PROF: 37%
Market capitalization -- CATX: $256.95M vs. PROF: $125.27M
CATX [@Medical/Nursing Services] is valued at $256.95M. PROF’s [@Medical/Nursing Services] market capitalization is $125.27M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, PROF is a better buy in the long-term than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 4 TA indicator(s) are bullish while PROF’s TA Score has 4 bullish TA indicator(s).

  • CATX’s TA Score: 4 bullish, 5 bearish.
  • PROF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PROF is a better buy in the short-term than CATX.

Price Growth

CATX (@Medical/Nursing Services) experienced а +2.98% price change this week, while PROF (@Medical/Nursing Services) price change was -7.83% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

CATX is expected to report earnings on Nov 18, 2025.

PROF is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($257M) has a higher market cap than PROF($125M). CATX YTD gains are higher at: 8.464 vs. PROF (-45.140). PROF has higher annual earnings (EBITDA): -41.56M vs. CATX (-94.48M). CATX has more cash in the bank: 192M vs. PROF (35.2M). CATX has less debt than PROF: CATX (3.57M) vs PROF (4.81M). PROF has higher revenues than CATX: PROF (11.8M) vs CATX (0).
CATXPROFCATX / PROF
Capitalization257M125M206%
EBITDA-94.48M-41.56M227%
Gain YTD8.464-45.140-19%
P/E RatioN/AN/A-
Revenue011.8M-
Total Cash192M35.2M545%
Total Debt3.57M4.81M74%
FUNDAMENTALS RATINGS
CATX vs PROF: Fundamental Ratings
CATX
PROF
OUTLOOK RATING
1..100
5421
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
6291
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (42) in the null industry is in the same range as CATX (63) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

PROF's Profit vs Risk Rating (100) in the null industry is in the same range as CATX (100) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

CATX's SMR Rating (97) in the Biotechnology industry is in the same range as PROF (99) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's Price Growth Rating (62) in the Biotechnology industry is in the same range as PROF (91) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PROF (100) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXPROF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCBFF18.410.51
+2.84%
Standard Chartered PLC
QUCT1800.00N/A
N/A
Queen City Investments, Inc.
HLMMF38.80N/A
N/A
Holmen AB
SGPPY6.36N/A
N/A
Spar Group, Ltd.
CDTI1.69-0.01
-0.59%
CDTI Advanced Materials, Inc.

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been loosely correlated with RBOT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CATX jumps, then RBOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-2.26%
RBOT - CATX
40%
Loosely correlated
-0.35%
SHC - CATX
36%
Loosely correlated
+0.77%
BJDX - CATX
33%
Loosely correlated
+2.84%
MTD - CATX
30%
Poorly correlated
+1.39%
FLGT - CATX
29%
Poorly correlated
-0.14%
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and MTD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and MTD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-6.79%
MTD - PROF
28%
Poorly correlated
+1.39%
NYXH - PROF
26%
Poorly correlated
+4.04%
A - PROF
26%
Poorly correlated
+0.21%
CATX - PROF
24%
Poorly correlated
-2.26%
QTRX - PROF
24%
Poorly correlated
+5.32%
More